A detailed history of Org Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Org Partners LLC holds 49 shares of VRTX stock, worth $20,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 52 5.77%
Holding current value
$20,000
Previous $24,000 8.33%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$460.0 - $505.78 $1,380 - $1,517
-3 Reduced 5.77%
49 $22,000
Q2 2024

Jul 16, 2024

BUY
$392.81 - $485.53 $17,283 - $21,363
44 Added 550.0%
52 $24,000
Q1 2024

May 06, 2024

SELL
$407.69 - $446.08 $2,853 - $3,122
-7 Reduced 46.67%
8 $3,000
Q4 2023

Jan 29, 2024

SELL
$343.0 - $410.68 $14,406 - $17,248
-42 Reduced 73.68%
15 $6,000
Q3 2023

Nov 03, 2023

SELL
$338.18 - $362.46 $1,352 - $1,449
-4 Reduced 6.56%
57 $15.6 Million
Q2 2023

Jul 25, 2023

BUY
$314.42 - $351.91 $19,179 - $21,466
61 New
61 $21.3 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Org Partners LLC Portfolio

Follow Org Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Org Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Org Partners LLC with notifications on news.